Vaginal infectious diseases and current approaches to their diagnosis and treatment


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To carry out a systematic analysis of the data available in the current literature on the role of bacterial vaginosis (BV) and Candida vulvovaginitis (CVV) in female sexual and reproductive dysfunction and on current approaches to their diagnosis and treatment. Material and methods. The review includes the data of foreign and Russian articles published in the past 10 years and found in electron bibliographic databases on this topic. Results. The clinical significance of two most common vaginal infectious diseases - BV and CVV: lower quality of life in a woman; frequent recurrences, an ability to cause urogenital diseases; and their association with poor pregnancy outcomes is described. It is shown that a concurrence of these diseases is observed in a considerable number of cases and the use of combined drugs is an optimal approach to therapy for these co-infections. Conclusion. The substantial unfavorable impact of BV and CVV on female reproductive function necessitates their timely and accurate diagnosis and effective treatment. The high rate of vaginal infections provides a rationale for the expediency of using combined medications.

Full Text

Restricted Access

About the authors

Alevtina Mikhailovna Savicheva

D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology

Email: savitcheva@mail.ru
Doctor of Medical Sciences, Professor, Head of Laboratory of Microbiology

Elena Vasilyevna Shipitsyna

D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology

Email: shipitsyna@inbox.ru
Doctor of Biological Sciences, Senior Researcher, Laboratory of Microbiology

Nadezda Evgenyevna Vorobyeva

D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology

Email: sergiognezdo@yandex.ru
PhD, Researcher at the Department of Gynecological Endocrinology

References

  1. Mylonas I., Bergauer F. Diagnosis of vaginal discharge by wet mount microscopy: a simple and underrated method. Obstet. Gynecol. Surv. 2011; 66(6): 359-68.
  2. Мирзабалаева А.К., Долго-Сабурова Ю.В. Кандидоз гениталий и бактериальный вагиноз в практике акушера-гинеколога. Проблемы медицинской микологии. 2004; 6(3): 18-24. [Mirzabalaeva A.K., Dolgo-Saburova YU.V. Candidiasis of the genitalia and bacterial vaginosis in practice of obstetrician and gynecologist. Problemy medicinskoj mikologii. 2004; 6 (3): 18-24. (in Russian)]
  3. Sherrard J., Donders G., White D., Jensen J.S. European (IUSTI/WHO) guideline on the management of vaginal discharge, 2011. Int. J. STD & AIDS. 2011; 22(8): 421-9.
  4. Российское общество акушеров-гинекологов. Диагностика и лечение заболеваний, сопровождающихся патологическими выделениями из половых путей женщин: клинические рекомендации. М.: ГОЭТАР-Медиа; 2013. 47с. [Russian Society of Obstetricians and Gynecologists. Diagnosis and treatment of diseases characterized by pathological vaginal discharge: clinical recommendations. М.: GEHOTAR-Media. 2013; 47 p. (in Russian)]
  5. Симбарская М.Л. Особенности местного иммунитета слизистой оболочки влагалища при хроническом рецидивирующем кандидозе гениталий и бактериальном вагинозе у женщин репродуктивного возраста: дисс.. канд. мед. наук. СПб.; 2015. 137 с. [Simbarskaya M.L. Local immunity of the mucous membrane of the vagina in recurrent candidiasis of the genitalia and bacterial vaginosis. Avtoref. diss.. kand. med. nauk. SPb: 2015; 137 p. (in Russian)]
  6. Spiegel C.A. Bacterial vaginosis. Rev. Med. Microbiol. 2002; 13(2): 43-51.
  7. Fredricks D.N., Fiedler T.L., Marrazzo J.M. Molecular identification of bacteria associated with bacterial vaginosis. N. Engl. J. Med. 2005; 353(18): 1899-911.
  8. Федеральные клинические рекомендации по ведению больных урогенитальным кандидозом. М.; 2015. Доступно по: http://www.cnikvi.ru/ docs/clinic_recs/infektsii-peredavaemye-polovym-putem/ [Federal clinical recommendations on the management of urogenital candidiasis. М.; 2015. http://www.cnikvi.ru/docs/clinic_recs/infektsii-peredavaemye-polovym-putem/ (in Russian)]
  9. Савичева А.М. Диагностика и лечение урогенитального кандидоза. Трудный пациент. 2006; 4(9): 28-32. [Savicheva А.М. Diagnosis and treatment of urogenital candidiasis. Trudnyj pacient. 2006; 4 (9): 28-32. (in Russian)]
  10. Савичева А.М., Кисина В.И., Соколовский Е.В., Башмакова М.А., Гриненко Г.В., Смирнова Т.С., Мартикайнен З.М., Рыбина Е.В., Шипицына Е.В., Игнатовский А.В., Красносельских Т.В., Литвиненко И.В., Брилене Т., Домейка М. Кандидозный вульвовагинит. Методические рекомендации для врачей. СПб.: Изд-во Н-Л; 2009. 80с. [Savicheva A.M., Kisina V.I., Sokolovskij E.V., Bashmakova M.A., Grinenko G.V., Smirnova T.S. et al. Candidal vulvovaginitis. Recommendatons for physicians. SPb: Izd-vo N-L; 2009. (in Russian)]
  11. Федеральные клинические рекомендации по ведению больных бактериальным вагинозом. М.; 2015. Доступно по: http://www.cnikvi.ru/ docs/clinic_recs/infektsii-peredavaemye-polovym-putem/ [Federal clinical recommendations on the management of bacterial vaginosis. М.; 2015. http:// www.cnikvi.ru/docs/clinic_recs/infektsii-peredavaemye-polovym-putem/ (in Russian)]
  12. Schwebke J.R., Weiss H.L. Interrelationships of bacterial vaginosis and cervical inflammation. Sex. Transm. Dis. 2002; 29(1): 59-64.
  13. Allsworth J.E., Peipert J.F. Severity of bacterial vaginosis and the risk of sexually transmitted infection. Am. J. Obstet. Gynecol. 2011; 205(2): 113. e1-6.
  14. Taylor B.D., Darville T., Haggerty C.L. Does bacterial vaginosis cause pelvic inflammatory disease. Sex. Transm. Dis. 2013; 40(2): 117-22.
  15. Denney J.M., Culhane J.F. Bacterial vaginosis: a problematic infection from both a perinatal and neonatal perspective. Semin. Fetal Neonatal Med. 2009; 14(4): 200-3.
  16. Donati L., Di Vico A., Nucci M., Quagliozzi L., Spagnuolo T., Labianca A. et al. Vaginal microbial flora and outcome of pregnancy. Arch. Gynecol. Obstet. 2010; 281(4): 589-600.
  17. Romero R., Chaiworapongsa T., Kuivaniemi H., Tromp G. Bacterial vaginosis, the inflammatory response and the risk of preterm birth: a role for genetic epidemiology in the prevention of preterm birth. Am. J. Obstet. Gynecol. 2004; 190(6): 1509-19.
  18. Hay P. Recurrent bacterial vaginosis. Curr. Infect. Dis. Rep. 2000; 2(6): 506-12.
  19. Eschenbach D.A. Chronic vulvovaginal candidiasis. N. Engl. J. Med. 2004; 351(9): 851-2.
  20. Behzadi P., Behzadi E., Ranjbar R. Urinary tract infections and Candida albicans. Cent. Eur. J. Urol. 2015; 68(1): 96-101.
  21. Тихомиров А.Л., Сарсания С.И. Особенности кандидозного вульвовагинита у беременных на современном этапе. Фарматека. 2009; 9: 68-74. [Tihomirov A.L., Sarsaniya S.I. Current features of candidal vulvovaginitis in pregnancy. Farmateka. 2009; 9: 68-74. (in Russian)]
  22. Буслаева Г.Н., Самсыгина Г.А. Кандидоз новорожденных и детей первых месяцев жизни. М.: ГЭОТАР-Медиа; 2008. 114с. [Buslaeva G.N., Samsygina G.A. Candidiasis in newborn infants and children in first months of life. M.: GEHOTAR-Media; 2008;114 p. (in Russian)]
  23. Amsel R., Totten P.A., Spiegel C.A., Chen K.C., Eschenbach D., Holmes K.K. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am. J. Med. 1983; 74(1): 14-22.
  24. Nugent R.P., Krohn M.A., Hillier S.L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J. Clin. Microbiol. 1991; 29(2): 297-301.
  25. Анкирская А.С., Муравьёва В.В. Интегральная оценка состояния микробиоты влагалища. Диагностика оппортунистических вагинитов (медицинская технология). М.; 2011. [Ankirskaya A.S., Muravyova V.V. Integral evaluation of the vaginal microbiota. Diagnosis of opportunistic infections (medical technology). М; 2011. (in Russian)]
  26. Аксенова О.А. К оценке состояния микрофлоры генитального тракта с помощью ПЦР. Журнал кожных и венерических болезней. 2005; 6: 60-6. [Aksenova O.A. Evaluation of the microflora of the genital tract using PCR. Zhurnal kozhnyh i venericheskih boleznej. 2005; 6: 60-6. (in Russian)]
  27. Липова Е.В., Хрзаян Р.С. Эффективность монотерапии бактериального вагиноза и урогенитального кандидоза тержинаном - комбинированным местнодействующим препаратом. Российский вестник акушера-гинеколога. 2006; 6(5): 66-8. [Lipova E.V., Hrzayan R.S. Effectiveness of the monotherapy of bacterial vaginosis and urogenital candidiasis with Terzhinan - a combined topical. Rossijskij vestnik akushera-ginekologa. 2006; 6 (5): 66-8. (in Russian)]
  28. Тихомиров А.Л., Олейник Ч.Г. Инфекции влагалища: взгляд гинеколога. Рациональная терапия кандидозного и смешанных вульвовагинитов. Венеролог. 2006; 2: 22-4. [Tihomirov A.L., Olejnik CH.G. Infections of the vagina: a view of gynecologist. Rational therapy of candida and concomitant vulvovaginitis. Venerolog. 2006; 2: 22-24. (in Russian)]
  29. Rivers C.A., Adaramola O.O., Schwebke J.R. Prevalence of bacterial vaginosis and vulvovaginal candidiasis mixed infection in a southeastern American STD clinic. Sex. Transm. Dis. 2011; 38(7): 672-4.
  30. Moodley P., Connolly C., Sturm A.W. Interrelationships among human immunodeficiency virus type 1 infection, bacterial vaginosis, trichomoniasis, and the presence of yeasts. J. Infect. Dis. 2002; 185(1): 69-73.
  31. Мирзабалаева А.К., Долго-Сабурова Ю.В. Особенности интравагинальной терапии вульвовагинального кандидоза у женщин. Гинекология. 2013; 15(6): 49-53. [Mirzabalaeva A.K. Dolgo-Saburova YU.V. Intravaginal therapy of vulvovaginal candidiasis in women. 2013; 6: 49-53. (in Russian)]
  32. Seidman L.S., Skokos C.K. An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis. Infect. Dis. Obstet. Gynecol. 2005;13(4): 197-206.
  33. Brown D., Henzl M.R., Kaufman R.H. Butoconazole nitrate 2% for vulvovaginal candidiasis. New, single-dose vaginal cream formulation vs. seven-day treatment with miconazole nitrate. Gynazole 1 Study Group. J. Reprod. Med. 1999; 44(11): 933-8.
  34. Levinson R.S., Mitan S.J., Steinmetz J.I., Gattermeir D.J., Schumacher R.J., Joffrion J.L. An open-label, two-period, crossover study of the systemic bioavailability in healthy women of clindamycin phosphate from two vaginal cream formulations. Clin. Ther. 2005; 27(12): 1894-900.
  35. McCormack W.M., Covino J.M., Thomason J.L., Eschenbach D.A., Mou S., Kapernick P. et al. Comparison of clindamycin phosphate vaginal cream with triple sulfonamide vaginal cream in the treatment of bacterial vaginosis. Sex. Transm. Dis. 2001; 28(10): 569-75.
  36. Sobel J., Peipert J.F., McGregor J.A., Livengood C., Martin M., Robbins J. et al. Efficacy of clindamycin vaginal ovule (3-day treatment) vs. clindamycin vaginal cream (7-day treatment) in bacterial vaginosis. Infect. Dis. Obstet. Gynecol. 2001; 9(1): 9-15.
  37. Савичева А.М., Шипицына Е.В. Бактериальный вагиноз и беременность: обзор литературы. Гинекология. 2012; 14(3): 38-43. [Savicheva A.M., Shipitsina E.V. Bacterial vaginosis and pregnancy: literature review. Ginekologiya. 2012; 3: 38-43. (in Russian)]
  38. Байрамова Г.Р., Прилепская В.Н., Цаллагова Е.В. Оценка эффективности и безопасности применения препарата «Клиндацин» в терапии больных с бактериальным вагинозом. Гинекология. 2006; 8(5): 14-6. [Bajramova G.R., Prilepskaya V.N., Callagova E.V. Evaluation of the effectiveness and safety of the antibiotic «Klindacin» in the therapy of patients with bacterial vaginosis. Ginekologiya. 2006; 5-6: 14-6. (in Russian)]
  39. Абашова Е.И., Боровик Н.В., Мартикайнен З.М., Савичева А.М., Тарасова М.А. Эффективность клиндамицина фосфата при лечении бактериального вагиноза у больных сахарным диабетом 1 типа. Акушерство и гинекология. 2006; 6: 46-9. [Abashova E.I., Borovik N.V., Martikajnen Z.M., Savicheva A.M., Tarasova M.A. Effectiveness of clindamycin phosphate for the treatment of bacterial vaginosis in patients with diabetes mellitus type 1. Akusherstvo i ginekologiya. 2006; 6: 46-9. (in Russian)]
  40. Тихомиров А.Л., Олейник Ч.Г. Современные принципы лечения бактериального вагиноза. Фарматека. 2005; 15: 34-7. [Tihomirov A.L., Olejnik C.G. Modern principles of the treatment of bacterial vaginosis. Farmateka. 2005; 15; 34-7. (in Russian)]
  41. Merabet J., Thompson D., Saul Levinson R. Advancing vaginal drug delivery. Expert Opin. Drug Deliv. 2005; 2(4): 769-77.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies